87 search results for: type 2 inflammation

How Does Protective <b>Type</b> <b>2</b> Immunity Become Harmful <b>Type</b> <b>2</b> <b>Inflammation</b>?
Dermatology
How Does Protective Type 2 Immunity Become Harmful Type 2 Inflammation?
expert video

In this video from the March 2025 ADVENT symposium in Orlando, Florida, Dr. Eric Simpson discusses how protective type 2 immunity can become dysregulated, leading to harmful type 2 inflammation. The associated inflammatory process can contribute to the pathophysiology of several dermatological diseases, including AD, PN, CSU, and BP.

View more
Spotlight on <b>Type</b> <b>2</b> <b>Inflammation</b> in the Upper and Lower Airways
Pulmonology
Spotlight on Type 2 Inflammation in the Upper and Lower Airways
expert video

In this video soundbite from the EAACI 2025 symposium, Dr. Zuzana Diamant explains pathophysiological mechanisms underlying asthma and CRSwNP, and how type 2 inflammatory cytokines drive airway remodelling in patients with severe asthma. Additionally, patients with co-existing asthma and CRSwNP have a higher type 2 inflammatory burden than patients with asthma alone.

View more
How Does Protective <b>Type</b> <b>2</b> Immunity Become Harmful <b>Type</b> <b>2</b> <b>Inflammation</b>?
Dermatology
How Does Protective Type 2 Immunity Become Harmful Type 2 Inflammation?
expert video

In this video soundbite from the March 2025 ADVENT symposium in Orlando, Florida, Dr. Eric Simpson explains how protective type 2 immunity can become dysregulated, leading to harmful type 2 inflammation.

View more
Coexisting <b>Type</b> <b>2</b> Inflammatory Diseases Can Add to the Patient Overall Disease Burden
Type 2 Inflammation
Coexisting Type 2 Inflammatory Diseases Can Add to the Patient Overall Disease Burden
expert video

In this soundbite video from the April 2025 ADVENT Forum in Lisbon, Portugal, Prof. Oscar Palomares highlights how patients with type 2 inflammatory diseases often experience multimorbidities, with overlapping symptoms that amplify their overall disease burden and impact quality of life.

View more
Exploring the Mechanisms of FeNO Production in the Lungs
Pulmonology
Exploring the Mechanisms of FeNO Production in the Lungs
videoanimation

Explore how type 2 inflammation drives the production of FeNO in severe asthma

View more
ERS 2026
Congress
5
September
2026
Congress
ADVENT at ERS 2026

Join Sanofi and Regeneron for four educational symposia on asthma, COPD, and the unified airway.

Gastro Forum <b>2</b>0<b>2</b>5 | EoE: How Far We've Come
Gastroenterology
Gastro Forum 2025 | EoE: How Far We've Come
videoanimation

Prof. Salvatore Oliva and Dr. Milli Gupta discuss the evolution in understanding EoE and the impact of chronic, underlying type 2 inflammation.

View more
Mechanisms of Production and Clinical Impact of IgE
Pulmonology
Mechanisms of Production and Clinical Impact of IgE
videoanimation

Explore how type 2 inflammation drives the production of IgE in severe asthma

View more
ERS <b>2</b>0<b>2</b>6 | Distal Airways, Central Role? Clinical Insights Into <b>Type</b> <b>2</b> Severe Asthma
Pulmonology
ERS 2026 | Distal Airways, Central Role? Clinical Insights Into Type 2 Severe Asthma
expert video

Join experts Frederik Trinkmann, Monica Kraft, and Arnaud Bourdin on an ADVENT educational symposium, “Distal Airways, Central Role? Clinical Insights Into Type 2 Severe Asthma."

View more
Interplay of Barrier Dysfunction and <b>Type</b> <b>2</b> <b>Inflammation</b> in EoE
Gastroenterology
Interplay of Barrier Dysfunction and Type 2 Inflammation in EoE
expert video

Learn from Prof. Seema Aceves about the interconnectivity of type 2 inflammation and barrier dysfunction in mediating EoE pathophysiology.

View more
IFOS <b>2</b>0<b>2</b>3 | <b>Type</b> <b>2</b> <b>Inflammation</b> and Clinically Relevant Improvements in CRSwNP
On Demand
IFOS 2023 | Type 2 Inflammation and Clinically Relevant Improvements in CRSwNP

Dr. Stella Lee and Profs. Peter Hellings and Wytske Fokkens discuss type 2 inflammation, partnering with patients to improve outcomes, and real-world data on biologic effectiveness in CRSwNP.